Changes in inducible nitric oxide synthase (iNOS) mRNA and protein expression in preclinical models representing various clinical groups of pulmonary hypertension (PH) in comparison to the respective controls *. The gene discussed is NOS2; the disease is pulmonary arterial hypertension.